Business Context and Reporting Period
Company: InMed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 18, 2024
Jurisdiction: British Columbia, Canada
Trading Symbol: INM (Nasdaq Stock Market LLC)
Emerging Growth Company: Yes
Key Financial Metrics
This filing is a current report regarding a regulatory disclosure event and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes to financial position or operations are reported in this document. The filing serves solely to announce an upcoming investor relations event.
Guidance, Outlook, and Management Commentary
Upcoming Event: The Company announced it will participate in the Water Tower Research Fireside Chat Series on January 25, 2024, at 1:00 pm ET.
Regulatory Status: The information provided in Item 7.01 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act. It shall not be deemed incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the date and time of the Water Tower Research Fireside Chat (January 25, 2024, 1:00 pm ET).
- Review the attached news release (Exhibit 99.1) for specific details regarding the event content.
- Confirm the company's status as an Emerging Growth Company for potential accounting standard implications.
- Note that this 8-K does not contain updated financial results; refer to the most recent 10-K or 10-Q for financial data.